Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2

Fecal diagnostics in combination with serology: best test to establish STEC-HUS

(2016) Kioa L. Wijnsma et al.   PEDIATRIC NEPHROLOGY

Antibiotic treatment of verocytotoxin-producingEscherichia coli(VTEC) infection: a systematic review and a proposal

(2015) Morten Agger et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Assessing the Public Health Risk of Shiga Toxin-Producing Escherichia coli by Use of a Rapid Diagnostic Screening Algorithm

(2015) Richard F. de Boer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement

(2015) Lars Pape et al.   MEDICINE

Comprehensive Characterization of Escherichia coli O104:H4 Isolated from Patients in the Netherlands

(2015) Mithila Ferdous et al.   Frontiers in Microbiology

Eculizumab hepatotoxicity in pediatric aHUS

(2014) Wesley Hayes et al.   PEDIATRIC NEPHROLOGY

Hemolytic uremic syndrome

(2014) Caterina Mele et al.   Seminars in Immunopathology

Renal and neurological involvement in typical Shiga toxin-associated HUS

(2012) Howard Trachtman et al.   Nature Reviews Nephrology

Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics

(2012) Lianne M. Geerdink et al.   PEDIATRIC NEPHROLOGY

Surveillance of Hemolytic Uremic Syndrome in Children Less Than 15 Years of Age, a System to Monitor O157 and Non-O157 Shiga Toxin-Producing Escherichia coli Infections in France, 1996–2006

(2009) Emmanuelle Espié et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL